Kidney Cancer Coverage From Every Angle
Advertisement
Advertisement

Laurence Albiges, MD, PhD, on RCC: Update on Checkpoint Inhibitors

Posted: Monday, February 12, 2018

Laurence Albiges, MD, PhD, of the Gustave Roussy Cancer Centre, discusses nivolumab, her study findings on its safety and efficacy in metastatic disease, and how checkpoint inhibitors fit into the evolution of treatment for renal cell carcinoma.